In light of these financial results, OptiNose revised its 2024 sales forecast for Xhance, its nasal spray treatment, to a range of $75 million to $79 million. Despite this adjustment, the company ...

despite taking fluticasone nasal spray daily and loratadine daily. Patient endorsed history of chronic sinusitis with nasal polyps and underwent sinus surgery twice in the past. He denied ...

Thus, the study concluded that all three INCS benefitted AR (10) Fluticasone furoate nasal spray for pediatric AR: Another double-blind, placebo-controlled, multicenter randomized controlled study ...

Nasal Steroid Sprays for the Treatment of Allergies In February 2015, Flonase (fluticasone) nasal spray became available OTC. Flonase is the second intranasal corticosteroid nasal (INS) spray to be ...

Optinose (NASDAQ: OPTN) has announced preliminary unaudited net product revenue of $22.4 million for the fourth quarter of ...

Nasal sprays can treat congestion and other symptoms of seasonal allergies or a cold. They work by delivering a fine mist of medication into your nostrils. Since the lining of your nose is rich with ...

Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.